• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Does Vigorous Physical Activity Further Reduce Risk for Cardiovascular Disease?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Physical activity is associated with a decreased risk of cardiovascular disease (CVD), but whether vigorous physical activity is associated with a further decreased risk of CVD is not well known
  • Ramakrishnan et al. (PLos Medicine, 2021) used UK Biobank data to examine the association between accelerometer-measured moderate, vigorous, and total physical activity and incident CVD

METHODS:

  • Population-based, longitudinal cohort study (UK Biobank)
  • Participants
    • Adults aged 40 to 69 years
    • Without prior or concurrent CVD
  • Study design
    • Participants wore an accelerometer on their dominant wrist for 7 days
    • Total volume of physical activity (PA) was measured using average vector magnitude in milli-gravity (mg) units, a metric that has been validated against the gold-standard measure for energy expenditure
    • Definitions
      • Moderate physical activity: Percentage time spent at 100 to 400 milli-gravity units
      • Vigorous physical activity: Percentage time spent >400 milli-gravity units
    • Adjustments were made for confounding (such as age, smoking, sex, ethnicity, alcohol use, area-based social deprivation)
    • Incident CVD was defined as the first hospital admission or death from CVD

RESULTS:

  • 90,211 participants
  • Participants in the lowest category of total PA
    • Smoked more
    • Had higher body mass index and C-reactive protein
    • Were diagnosed with hypertension

Linear Dose-Response Relationship Between PA and Risk Of CVD

  • Moderate PA
    • Hazard ratio (HR) 3rd to 4th (lowest) quarter of distribution: 0.71 (95% CI, 0.65 to 0.77)
    • HR 2nd to 4th HR 0.59 (95% CI, 0.54 to 0.65)
    • HR 1st to 4th: HR 0.46 (95% CI, 0.41 to 0.51)
  • Vigorous PA
    • HR 3rd to 4th: HR 0.70 (95% CI, 0.64 to 0.77)
    • HR 2nd to 4th: HR 0.54 (95% CI, 0.49 to 0.59)
    • HR 1st to 4th: HR 0.41 (95% CI, 0.37 to 0.46)
  • Total volume of PA
    • HR 3rd to 4th: HR 0.73 (95% CI, 0.67 to 0.79)
    • HR 2nd to 4th: HR 0.63 (95% CI, 0.57 to 0.69)
    • HR 1st to 4th: HR 0.47 (95% CI, 0.43 to 0.52)

CONCLUSION:

  • More vigorous physical activity appears to be associated with a greater reduction in CVD risk, without an upper limit threshold
  • The authors conclude that

The finding of no threshold effect aligns with the recommendations of the UK Chief Medical Officer’s report on PA that “some physical activity is good but more is better”

Learn More – Primary Sources:

Accelerometer measured physical activity and the incidence of cardiovascular disease: Evidence from the UK Biobank cohort study

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite
< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

The Physical Activity Guidelines for Americans – HHS Recommendations
More From the PURE Study: Does Type of Exercise Matter When it Comes to Decreasing Mortality and CVD?  
Is Physical Activity Associated with Lower Risk of Fractures in Older Women?
The Relationship between Exercise and Heart Disease – Does Genetics Matter?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site